Pubblicazioni

Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

2019 - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Marampon, Francesco; Leoni, Flavio; Mancini, Andrea; Pietrantoni, Ilaria; Codenotti, Silvia; Letizia, Ferella; Megiorni, Francesca; Porro, Giuliana; Galbiati, Elisabetta; Pozzi, Pietro; Mascagni, Paolo; Budillon, Alfredo; Maggio, Roberto; Tombolini, Vincenzo; Fanzani, Alessandro; Gravina, Giovanni Luca; Festuccia, Claudio

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells

2016 - MOLECULAR AND CELLULAR ENDOCRINOLOGY

Rotondi, Sandra; Modarelli, Alessio; Oliva, Maria-Antonietta; Rostomyan, Liliya; Sanita, Patrizia; Ventura, Luca; Daly, Adrian F.; Esposito, Vincenzo; Angelucci, Adriano; Arcella, Antonietta; Giangaspero, Felice; Beckers, Albert; Jaffrain-Rea, Marie-Lise

Pubblicazioni

Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells